A5038152922- Economic and Financial Impacts of Cancer
- BRCA gene mutations in cancer
- Global Cancer Incidence and Screening
- Advances in Oncology and Radiotherapy
- Health Systems, Economic Evaluations, Quality of Life
- Lung Cancer Treatments and Mutations
- Genetic factors in colorectal cancer
- Prostate Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Healthcare Policy and Management
- Healthcare cost, quality, practices
- Head and Neck Cancer Studies
- Pharmaceutical industry and healthcare
- Nutrition, Genetics, and Disease
- Patient-Provider Communication in Healthcare
- Esophageal Cancer Research and Treatment
- Clinical practice guidelines implementation
- Ethics in Clinical Research
- Lung Cancer Research Studies
- Cancer Genomics and Diagnostics
- Multiple and Secondary Primary Cancers
- Salivary Gland Tumors Diagnosis and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Tumors and Oncological Cases
Mayo Clinic in Arizona
2023-2024
Arizona State University
2024
American College of Surgeons
2007-2016
University of South Carolina
2008
University of California, Los Angeles
2008
University of Michigan
2008
Columbia University
2008
Abstract Background We sought to examine the current state of cancer care for head and neck tumors in United States. therefore performed a retrospective, longitudinal study approximately 822,000 cases included National Cancer Data Base (NCDB) 1990 through 2004, representing 75% estimated incident diagnoses Methods All diagnosed reported NCDB during this interval were reviewed, descriptive statistics, grouped by disease host factors, analyzed over time compared with prior similar analysis...
The commencement of quality-improvement initiatives such as Pay for Performance and the Physician Consortium Improvement has underscored calls to evaluate quality cancer care on a patient level nationally representative samples.We sampled early-stage prostate cases diagnosed in 2000 through 2001 from American College Surgeons National Cancer Data Base explicitly reviewed medical records 2,775 men (weighted total = 55,160 cases) treated with radical prostatectomy or external-beam radiation...
The autosomal dominant cancer predisposition disorders hereditary breast and ovarian (HBOC) Lynch syndrome (LS) are genetic conditions for which early identification intervention have a positive effect on the individual public health. goals of this study were to determine whether germline screening using exome sequencing could be used efficiently identify carriers HBOC LS.
The authors assessed adherence with the College of American Pathologists (CAP) radical prostatectomy (RP) practice protocol in a national sample men who underwent RP for early-stage prostate cancer.Using National Cancer Data Base, identified nationally representative 1240 (unweighted) RP. For each patient, local cancer registrars performed an explicit medical record review to assess patient-level compliance surgical pathology report documentation 7 morphologic criteria (ie, quality...
Given the increased attention to quality and cost of medical care, Institute Medicine Centers for Medicare Medicaid Services have called performance measurement reporting. The clinical management prostate cancer has been outlined, yet is not intended describe care. Therefore, RAND researchers developed indicators early stage cancer. ACoS (American College Surgeons) used these perform first national assessment our knowledge care among men with undergoing expectant management.Information from...
173 Background: Many quality metrics of cancer care are process measures, based on whether a patient received recommended treatment for diagnosis and stage their disease. Survival is dependent characteristics, disease specifics, (surgery, systemic therapies, radiation). Some argue survival the ultimate measure quality. calculated from registry data may be better indication real effects new therapies as it contains broad representation patients who not meet eligibility criteria clinical...
195 Background: The Commission on Cancer’s (CoC) standards require accredited cancer programs to utilize a multidisciplinary team approach for treatment planning. A recent CoC survey sought characterize current planning (MTP) practice from the programs’ perspective. Methods: survey, administered 1,261 programs, included items structure and process, case presentation, clinical trials patient involvement. Each facility was designated report MTP one type: Breast, Gastrointestinal (GI), Lung,...
145 Background: Patient involvement in treatment decision-making has been well-studied. However, little is known about how patients are involved the MTP process prior to their consideration of options. Methods: An online survey was administered 1,261 Commission on Cancer (CoC)-accredited programs describe current practice. Survey items addressed team structure and process, case presentation, patient involvement. A total 797 (63%) facilities responded. Multiple aspects focusing initial...
Abstract Two inherited autosomal dominant cancer predisposition conditions - BRCA related hereditary breast and ovarian (HBOC) Lynch syndrome (LS) are termed Centers for Disease Control Prevention Tier 1 (CDCT1) genetic conditions, which early identification intervention have a positive impact on public health. Selection of individuals testing these is based personal family history. The goal this study was to evaluate whether screening in tertiary medical center using exome sequencing could...
6088 Background: RQRS is a cancer registry based tool for rapid case ascertainment and real-time care tracking using 5 National Quality Forum approved quality measures breast (BC) colon (CC) 1 American Society of Clinical Oncology, Comprehensive Cancer Network Commission on (CoC) endorsed rectal (RC) measure. was introduced in 2009 testing at selected CoC accredited programs. The purpose this study to evaluate the proportion cases with treatment administered 4 where concordant either...
34 Background: Since enactment of Healthy People 2000 (ODPHP.gov, nd), a focus has been to reduce disparity by achieving health equity across all people. We examined for five cancer quality measures with high performance rates (PRs) ( > 85%). Methods: Five developed the Commission on Cancer and endorsed National Quality Forum were evaluated potential ethnicity, insurance, Census Division disparities. Data from Database used examine hospital-level PRs adjuvant chemotherapy ER neg breast ca...